The Dangers of Vaping on Lung Health

Dec.26.2022
The Dangers of Vaping on Lung Health
E-cigarettes are not a safer alternative to smoking and can cause lung damage and cancer due to harmful chemicals.

Electronic cigarettes or e-cigarettes have become a popular alternative for those who want to quit smoking. However, the truth is that both e-cigarettes and traditional cigarettes are harmful and can have an impact on various organs in the body, including the lungs. Unfortunately, many individuals misunderstand the risks associated with e-cigarettes and tend to ignore their potential impact on lung health.


E-cigarettes are devices that heat liquid into an aerosol for inhalation into the lungs. Unlike traditional cigarettes which produce smoke by burning tobacco, e-cigarette liquids contain various combinations of ingredients, including nicotine, other chemicals, flavorings, and toxins.


In the past 24 to 36 months, I have seen a significant increase in the number of patients using electronic cigarettes," reported Stephen Broderick, a lung cancer surgeon at Johns Hopkins.


The following are a series of effects of e-cigarettes on the lungs that one needs to be aware of.


Popped popcorn lung


Popcorn lung, also known as bronchiolitis obliterans (BO), is a rare respiratory disease caused by damage to the small airways in the lungs. The disease was first discovered in popcorn factory workers. The culprit was identified as diacetyl, a food additive used to simulate the flavor of butter in microwave popcorn.


Acetoin is commonly added to e-cigarette liquids to improve their flavor. Inhaling this substance can cause inflammation of the smallest airways in the lungs and lead to permanent scarring, thereby causing difficulty in breathing. There is currently no permanent treatment for Popcorn Lung, which presents with symptoms such as coughing, wheezing, chest pain, and breathing difficulties.


2. Lipoid Pneumonia.


Unlike typical pneumonia caused by infection, lipoid pneumonia occurs when fatty acids (components of fat) enter the lungs. Lipoid pneumonia related to vaping occurs when oily substances in e-cigarettes are inhaled, triggering inflammation in the lungs. Symptoms of lipoid pneumonia include chronic cough, difficulty breathing, and coughing up mucus mixed with blood or containing blood.


According to Broderick, "There is no effective treatment for lipoid pneumonia other than supportive care, as the lungs will heal on their own. The most important thing you can do is determine the cause." He furthered his statement.


3. Primary spontaneous pneumothorax


Primary spontaneous pneumothorax or lung collapse occurs when there is a hole in the lung through which oxygen escapes. This may be a result of injury, such as gunshot or stabbing, or the rupture of a small tear in a bubble at the top of the lung.


Smoking and vaping e-cigarettes often increase the risk of these fluid-filled sacs or bubbles bursting, ultimately leading to collapsed lungs.


We always ask them if they smoke, and they often say, 'No, I don't smoke. But I use e-cigarettes.' We now advise patients that if they want to avoid future lung collapse and surgery, they should avoid smoking or using e-cigarettes.


Signs of pulmonary collapse include severe pain in the chest or shoulder and difficulty breathing. Oxygen therapy and rest may be necessary preparations to cure collapsed lungs. However, more serious cases may require a chest tube to drain the leaked oxygen from the body cavity or surgery to repair a hole in the lungs.


Lung Cancer


Electronic cigarettes may increase the risk of cancer due to the many chemicals they contain that can enter the lungs.


We know that smoking tobacco causes tiny particles to deposit deep in the bronchial tree and can lead to the development of cancer. Vaping may have a similar effect," said Broderick.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

EU ‘TPD3’ Enters Next Phase on Aug. 14 as Fragmented Vape and Nicotine Pouch Rules Push the Single Market Toward Regulatory Overhaul
EU ‘TPD3’ Enters Next Phase on Aug. 14 as Fragmented Vape and Nicotine Pouch Rules Push the Single Market Toward Regulatory Overhaul
A 12-week European Commission consultation on revising the Tobacco Products Directive and Tobacco Advertising Directive is due to close on Aug. 14, 2026. The Commission has identified e-cigarette flavours, disposable vapes, tobacco heating devices, nicotine pouches, nicotine-free e-cigarettes, packaging and digital marketing among areas for possible new EU rules. National regulations already vary significantly across the bloc, a fragmentation the Commission says creates internal-market barriers and distorts competition. No formal revised TPD/TAD legislative text has yet been published, with the Commission currently indicating December 2026 for the legislative initiative.
Aug.14
Indonesia’s BNN Pushes Total Vape Ban as Health Ministry Tightens Tobacco Packaging Rules, Putting $40 Billion Industry at Risk
Indonesia’s BNN Pushes Total Vape Ban as Health Ministry Tightens Tobacco Packaging Rules, Putting $40 Billion Industry at Risk
Indonesia is entering a new phase of debate over vape and tobacco regulation. The National Narcotics Agency (BNN) has proposed a total vape ban, with some lawmakers supporting stronger restrictions. At the same time, the Health Ministry is advancing tobacco and nicotine regulations under Government Regulation No. 28/2024, including measures such as plain packaging and product controls. Tobacco and vape industries have warned that tighter rules could affect a sector worth around $40 billion, supporting about 6 million jobs and contributing significant tax revenue.
Jul.27
UK HMRC Plans 30,000 Retail Enforcement Actions as Illegal Tobacco and Vape Sellers Face Tougher Crackdown
UK HMRC Plans 30,000 Retail Enforcement Actions as Illegal Tobacco and Vape Sellers Face Tougher Crackdown
The UK government has announced that HM Revenue & Customs (HMRC) will carry out more than 30,000 interventions targeting businesses and retail premises during the 2026-2027 financial year. The actions will focus on tax fraud, illegal goods sales and businesses involved in unlawful activities through retail channels. The government said illegal tobacco and illegal vape sales remain areas of concern. The move shows that UK enforcement against illegal nicotine products is expanding from import and supply channels toward retail-level oversight, alongside the upcoming introduction of the Vaping Products Duty.
Jul.24
Philippine Local Governments Urge Marcos to Prioritize Smoke- and Vape-Free Bill
Philippine Local Governments Urge Marcos to Prioritize Smoke- and Vape-Free Bill
The League of Municipalities of the Philippines (LMP) has urged President Ferdinand Marcos Jr. to prioritize the Smoke- and Vape-Free Bill, seeking a nationwide legal framework for tobacco and vape regulation. Local government leaders said national legislation would help standardize enforcement and strengthen public health measures. The proposal remains at the advocacy stage and has not yet become law.
Jul.29
Data|China’s January-May Vape Exports: U.S. Shipments Fall 13.8% as Japan Posts Fastest Growth
Data|China’s January-May Vape Exports: U.S. Shipments Fall 13.8% as Japan Posts Fastest Growth
According to China Customs export data analyzed by 2Firsts, the United States remained China’s largest destination for vape-related exports during January-May 2026 despite a 13.82% year-on-year decline in export value. Meanwhile, exports to Japan, Russia, Indonesia and the United Arab Emirates recorded strong growth, highlighting continued diversification across China’s export markets.
Special Report
Jun.29
Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
A new Swedish study found oral mucosal lesions in 79% of examined nicotine pouch users and 89% of tobacco-derived snus users, with different tissue-response patterns between the two categories. For manufacturers and regulators, the findings shift attention toward product formulation, flavouring, pouch materials and local oral exposure, not only whether a product contains tobacco. The study found no higher prevalence of caries or periodontal disease, but it could not establish causality, long-term outcomes or differences between individual products or designs.
Special Report
Jul.27